Abstract
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a biomarker that can be used to assess the risk for cardiovascular disease and events. In addition to being a useful marker of a risk factor, several studies suggest that Lp-PLA2 has a pathophysiologic role in the atherosclerotic disease process. In this article we review this aspect and its therapeutic implications.
Original language | English (US) |
---|---|
Pages (from-to) | 230-235 |
Number of pages | 6 |
Journal | Current atherosclerosis reports |
Volume | 10 |
Issue number | 3 |
DOIs | |
State | Published - Jun 2008 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine